" class="no-js "lang="en-US"> Acorda Launches TV Commercial for Parkinson’s Awareness Month
Friday, June 09, 2023

Acorda Launches INBRIJA® TV Commercial for Parkinson’s Awareness Month

Acorda Therapeutics today announced that it has launched an INBRIJA® (levodopa inhalation powder) television commercial for Parkinson’s Awareness Month.

The commercial will air on approximately 50 streaming services, including Hulu, the Disney Channel, and Paramount+, and be directed to households who have self-identified as being impacted by Parkinson’s disease. A digital “surround sound” campaign of INBRIJA-branded internet and social media content will coincide with the commercial. Viewers will be able to opt-in to obtain more information or speak directly with a nurse educator.

“Many people with Parkinson’s experience OFF periods, in which their symptoms return in between doses of their regularly scheduled medicines. These can be highly disruptive and over time cause them to narrow their lives. It’s important to educate those living with PD about the need to be proactive in addressing OFF periods, and to consider whether an on-demand medication such as INBRIJA may be helpful to them,” said Kerry Clem, Chief Commercial Officer of Acorda Therapeutics. “In addition, we are able to leverage the power of streaming services to reach those impacted by Parkinson’s significantly more cost-effectively than traditional broadcast tv advertising.”

  1. Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
  2. Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
  3. Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
  4. Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
  5. Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more